CPRT
Copart, Inc.
CPRT has the edge over RKLB overall, supported by lower modeled downside and stronger valuation.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
CPRT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
CPRT's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CPRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $32.00 | — |
| Current | 21x | $32.00 | — |
| Cheap | 24x | $37.74 | +18% |
| Fair | 34x | $53.05 | +66% |
| Expensive | 39x | $60.99 | +91% |
Historical ranges are pointers, not guarantees.
CPRT's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
CPRT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CPRT, but weaker profitability.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over CPRT on the outlook, with more favorable profitability expectations.
CPRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.66 | +7% |
| Q3 2026 | $1.55 | -2.5% |
| Q2 2026 | $1.60 | +4.6% |
| Q1 2026 | $1.59 | +6% |
| Q4 2025 | $1.63 | +14% |
| Q3 2025 | $1.59 | +14% |
| Q2 2025 | $1.53 | +7.7% |
| Q1 2025 | $1.50 | +7.9% |
| Q4 2024 | $1.43 | +5.1% |
CPRT has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
CPRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +2.4% |
| Q2 2026 | $1.2B | +2.1% |
| Q1 2026 | $1.1B | -3.6% |
| Q4 2025 | $1.2B | +0.7% |
| Q3 2025 | $1.1B | +5.2% |
| Q2 2025 | $1.2B | +7.5% |
| Q1 2025 | $1.2B | +14% |
| Q4 2024 | $1.1B | +12% |
CPRT's revenue grew through 2024 and has held roughly level since: $1.2B last quarter, up 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -4.7 points |
| Q2 2026 | 38% | +0.3 points |
| Q1 2026 | 35% | -2 points |
| Q4 2025 | 37% | +1.9 points |
| Q3 2025 | 37% | +3 points |
| Q2 2025 | 37% | -1.5 points |
| Q1 2025 | 37% | -0.6 points |
| Q4 2024 | 35% | -3.3 points |
CPRT has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over CPRT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
CPRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $278.7M | -21% |
| Q2 2026 | $503.3M | -20% |
| Q1 2026 | $57.9M | +1330% |
| Q4 2025 | $427.2M | +74% |
| Q3 2025 | $350.8M | +16% |
| Q2 2025 | $630.4M | +54% |
| Q1 2025 | $4M | -90% |
| Q4 2024 | $245.5M | +15% |
CPRT has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
CPRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +14.1M shares |
| 1 year | -2.1% | -20.7M shares |
| 3 years | -1% | -9.8M shares |
| 5 years | -0.4% | -4.3M shares |
| Available history | +0.2% | +2.2M shares |
CPRT has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1,000 |
| Q2 2026 | $1.4B |
| Q3 2020 | — |
| Q2 2020 | — |
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CPRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.0x | Net Cash |
| Q2 2026 | -1.8x | Net Cash |
| Q1 2026 | -2.8x | Net Cash |
| Q4 2025 | -2.7x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -2.1x | Net Cash |
CPRT has more cash than debt.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CPRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.4 | Neutral |
| Stochastic | 63.3 | Neutral |
CPRT's weekly RSI is 53 (neutral) and its Stochastic is 63 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
CPRT PE vs Industrials Sector
| Metric | CPRT | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 24x | 14% below |
| PE % | 7 | 58 | 51 pts below |
CPRT is trading at 21x earnings, a 14% discount to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
CPRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.9% above |
| 20 week MA | $29.8 | 7.3% above |
| 50 week MA | $33.3 | 3.8% below |
| 100 week MA | $42.3 | 24% below |
| 200 week MA | $45.1 | 29% below |
CPRT has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over CPRT on trend strength, trading above more of its moving averages.
CPRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.7 | $30.9 | +36% |
| 2021 | $30.9 | $36.5 | +18% |
| 2022 | $36.5 | $30.3 | -17% |
| 2023 | $30.3 | $49.0 | +62% |
| 2024 | $49.0 | $58.5 | +19% |
| 2025 | $58.5 | $39.3 | -33% |
| 2026 YTD | $39.3 | $32.0 | -19% |
CPRT has finished higher in four of the last six years. It's down 19% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over CPRT on returns for 2026, with the stronger performance.